Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness

OBJECTIVES: To assess the characteristics and risk factors for mortality in patients with severe coronavirus disease-2019 (COVID-19) treated with tocilizumab (TCZ), alone or in combination with corticosteroids (CS). METHODS: From March 17 to April 7, 2020, a real-world observational retrospective an...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubio-Rivas, Manuel, Ronda, Mar, Padulles, Ariadna, Mitjavila, Francesca, Riera-Mestre, Antoni, García-Forero, Carlos, Iriarte, Adriana, Mora, Jose M., Padulles, Nuria, Gonzalez, Monica, Solanich, Xavier, Gasa, Merce, Suarez-Cuartin, Guillermo, Sabater, Joan, Perez-Fernandez, Xose L., Santacana, Eugenia, Leiva, Elisabet, Ariza-Sole, Albert, Dallaglio, Paolo D., Quero, Maria, Soriano, Antonio, Pasqualetto, Alberto, Koo, Maylin, Esteve, Virginia, Antoli, Arnau, Moreno-Gonzalez, Rafael, Yun, Sergi, Cerda, Pau, Llaberia, Mariona, Formiga, Francesc, Fanlo, Marta, Montero, Abelardo, Chivite, David, Capdevila, Olga, Bolao, Ferran, Pinto, Xavier, Llop, Josep, Sabate, Antoni, Guardiola, Jordi, Cruzado, Josep M., Comin-Colet, Josep, Santos, Salud, Jodar, Ramon, Corbella, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537652/
https://www.ncbi.nlm.nih.gov/pubmed/33035673
http://dx.doi.org/10.1016/j.ijid.2020.09.1486

Ejemplares similares

Ejemplares similares